- Home
- / Lakewood-Amedex Biotherapeutics
Lakewood-Amedex Biotherapeutics
Lakewood-Amedex Biotherapeutics Summary
Company Summary
- Overview
- Lakewood-Amedex Biotherapeutics is a clinical-stage pharmaceutical company developing antimicrobial and antifungal therapeutics to treat infectious diseases. It provides Nu-3, an antimicrobial candidate that targets a range of Gram-positive, Gram-negative, and antibiotic-resistant bacteria.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- University Park, FL, US | view all locations
- Website
- https://lakewoodamedex.com/
- Cybersecurity rating
Table of Contents
Key People
Steve Parkinson, Executive Director, Chief Executive Officer and President
Thomas Pfisterer, Director
Patrick O'Connor, Chief Medical Officer
LocationsView all
2 locations detected
University Park, FL HQ
United States
8031 Cooper Creek Blvd #103
Sarasota, FL
United States
3030 University Pkwy
Lakewood-Amedex Biotherapeutics Financials
Summary Financials
- Cash (Q1, 2026)
- $11.7K
- EBIT (Q1, 2026)
- ($886.8K)